We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TBS:JSETiger Brands Limited Analysis

Data as of 2026-06-28 - not real-time

ZAC 29,350.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Tiger Brands is trading below its longer‑term moving averages, with the short‑term SMA sitting beneath the mid‑term SMA, signalling a bearish price bias. The RSI hovers in the mid‑50s, suggesting limited upside momentum, while the MACD histogram remains positive, hinting at a latent bullish undercurrent. Dividend yield stays attractive for income‑focused investors, yet the DCF model points to a fair value markedly lower than the current market price, implying overvaluation. Low beta underscores minimal market‑wide volatility exposure, but recent 30‑day price swings have been elevated and the stock has experienced a sizable historical drawdown, raising concerns about price stability. Fundamentally, revenue growth is modest, margins are solid, and cash flow comfortably covers the generous payout ratio, supporting dividend sustainability. Overall, the mix of defensive sector positioning, strong cash generation, and a high dividend makes the stock appealing for long‑term holders, but the current price premium and bearish technical setup warrant caution in the near term.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish technical alignment with price below key moving averages
  • Current price significantly above DCF fair value
  • Elevated short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong cash flow supporting dividend payouts
  • Defensive consumer‑staples positioning
  • Potential price correction toward intrinsic value

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend yield in a low‑beta sector
  • Solid profitability margins and ROE
  • Long‑run upside as market re‑prices the stock toward DCF estimate

Key Metrics & Analysis

Financial Health

Revenue Growth1.30%
Profit Margin9.59%
P/E Ratio13.8
ROE21.31%
ROA10.33%
Debt/Equity23.00
P/B Ratio3.9
Op. Cash FlowZAC4.6B
Free Cash FlowZAC2.4B

Technical Analysis

TrendBearish
RSI55.0
SupportZAC 26,722.00
ResistanceZAC 29,900.00
MA 20ZAC 28,833.95
MA 50ZAC 29,000.86
MA 200ZAC 32,081.31
MACDBullish
VolumeDecreasing
Fear & Greed Index88.55

Valuation

Fair ValueZAC 22,109.85
Target PriceZAC 35,666.66
Upside/Downside21.52%
GradeOvervalued
TypeValue
Dividend Yield5.65%

Risk Assessment

Beta0.13
Volatility19.20%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.